Brain scan breakthrough could sharpen dementia diagnosis
NCT ID NCT00917709
First seen May 19, 2026 · Last updated May 28, 2026 · Updated 2 times
Summary
This study looked at how changes in two brain chemical systems—acetylcholine and dopamine—relate to symptoms in people with Dementia with Lewy Bodies (DLB). Researchers used special scans (SPECT imaging) to measure these chemicals in 34 participants, including healthy volunteers. The goal was to see if these scans could help identify different types of DLB and improve diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Groupe Hospitalier Pellegrin - C.H.U. de Bordeaux
Bordeaux, 33076, France
Conditions
Explore the condition pages connected to this study.